Symptoms
Common signs and symptoms of Neuroblastoma include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Neuroblastoma.
Neuroblastoma develops when immature nerve cells called neuroblasts fail to mature properly during fetal development.
Neuroblastoma develops when immature nerve cells called neuroblasts fail to mature properly during fetal development. Instead of becoming healthy nerve cells or adrenal gland tissue, these cells continue multiplying and form tumors. Scientists believe this process begins before birth, explaining why most cases appear in very young children. The exact trigger that prevents normal cell maturation remains unclear, but researchers have identified specific genetic changes that occur in neuroblastoma cells.
Most cases arise spontaneously without any inherited genetic defect.
Most cases arise spontaneously without any inherited genetic defect. However, about 1-2% of neuroblastomas run in families, suggesting some children inherit genetic mutations that increase their risk. These hereditary cases often appear earlier than sporadic ones and may affect multiple family members across generations. Research has identified mutations in genes like ALK and PHOX2B that can predispose children to developing neuroblastoma.
Environmental factors during pregnancy have been studied extensively, but no clear external causes have been established.
Environmental factors during pregnancy have been studied extensively, but no clear external causes have been established. Unlike many adult cancers, neuroblastoma doesn't appear linked to radiation exposure, chemical exposure, or lifestyle factors. The tumor seems to result from random errors in normal fetal development rather than external influences, which explains why prevention strategies remain limited and why parents shouldn't blame themselves when their child develops this condition.
Risk Factors
- Age under 5 years, especially infancy
- Family history of neuroblastoma
- Inherited genetic mutations in ALK or PHOX2B genes
- Certain congenital abnormalities
- Male gender (slightly higher risk)
- Hirschsprung disease
- Central hypoventilation syndrome
Diagnosis
How healthcare professionals diagnose Neuroblastoma:
- 1
Diagnosing neuroblastoma typically begins when parents or doctors notice concerning symptoms like abdominal masses, unexplained pain, or unusual behavioral changes in a young child.
Diagnosing neuroblastoma typically begins when parents or doctors notice concerning symptoms like abdominal masses, unexplained pain, or unusual behavioral changes in a young child. The initial evaluation includes a thorough physical examination, during which doctors feel for lumps or masses and check for swollen lymph nodes. Blood tests help assess overall health and look for elevated levels of catecholamines - chemicals produced by neuroblastoma cells that can be detected in blood and urine samples.
- 2
Imaging studies play a crucial role in diagnosis and staging.
Imaging studies play a crucial role in diagnosis and staging. Doctors usually start with ultrasound or CT scans to locate tumors and assess their size and spread. MRI scans provide detailed images of tumors near the spine or brain, while specialized nuclear medicine scans using MIBG (meta-iodobenzylguanidine) can detect neuroblastoma cells throughout the body. These scans help determine whether the cancer has spread to bones, bone marrow, or other organs.
- 3
Definitive diagnosis requires a tissue biopsy, where doctors remove a small sample of tumor tissue for microscopic examination.
Definitive diagnosis requires a tissue biopsy, where doctors remove a small sample of tumor tissue for microscopic examination. Pathologists look for characteristic cell patterns and perform genetic tests to identify specific chromosomal changes that help predict how aggressive the tumor will be. Bone marrow biopsies may also be necessary to check for cancer spread. The entire diagnostic process typically takes 1-2 weeks, during which medical teams work quickly to develop appropriate treatment plans based on the tumor's location, size, genetic features, and whether it has spread beyond its original site.
Complications
- Neuroblastoma complications can arise from both the tumor itself and the intensive treatments required.
- The cancer may compress surrounding organs, causing breathing difficulties if located in the chest, or interfere with kidney function when growing near the adrenal glands.
- Tumors along the spine can press on nerve roots, potentially causing weakness or paralysis.
- When neuroblastoma spreads to bones, it causes significant pain and may lead to fractures or bone marrow failure affecting blood cell production.
- Treatment-related complications vary depending on the therapies used but can include both short-term and long-term effects.
- Chemotherapy may cause temporary hair loss, increased infection risk, hearing problems, and kidney damage.
- High-dose treatment and stem cell transplant carry risks of serious infections and organ complications.
- Radiation therapy can affect growth and development of treated areas and may increase the risk of secondary cancers years later.
- Surgery near vital structures may result in organ damage or functional problems, though skilled pediatric surgeons minimize these risks through careful planning and advanced techniques.
Prevention
- No proven methods exist to prevent neuroblastoma because this cancer develops from random errors in fetal nerve cell development rather than external factors.
- Unlike many adult cancers, neuroblastoma isn't linked to environmental exposures, lifestyle choices, or preventable risk factors during pregnancy.
- Parents cannot reduce their child's risk through dietary changes, avoiding certain activities, or other preventive measures.
- For families with a history of neuroblastoma, genetic counseling can help assess the risk of inherited forms and discuss family planning options.
- Prenatal genetic testing may be available for families carrying known genetic mutations, though this accounts for less than 2% of cases.
- Research into the genetic basis of neuroblastoma continues, but currently no screening programs exist for the general population.
- The focus remains on early recognition of symptoms and prompt medical evaluation when concerning signs appear.
- Parents should seek medical attention if their young child develops persistent abdominal pain, unexplained masses, bone pain, or other warning signs.
- While prevention isn't possible, early diagnosis and treatment significantly improve outcomes for children with neuroblastoma.
Treatment for neuroblastoma varies dramatically based on risk classification, which considers the child's age, tumor location, genetic features, and extent of spread.
Treatment for neuroblastoma varies dramatically based on risk classification, which considers the child's age, tumor location, genetic features, and extent of spread. Low-risk cases may require only careful monitoring, as some neuroblastomas spontaneously regress without any intervention. When treatment is needed for low-risk disease, surgery alone often provides cure rates exceeding 95%. Surgeons aim to remove the entire tumor while preserving nearby organs and structures.
Intermediate and high-risk neuroblastomas require more intensive multimodal therapy combining surgery, chemotherapy, radiation, and newer targeted treatments.
Intermediate and high-risk neuroblastomas require more intensive multimodal therapy combining surgery, chemotherapy, radiation, and newer targeted treatments. Chemotherapy typically involves combinations of drugs like cyclophosphamide, doxorubicin, cisplatin, and etoposide given over several months. High-dose chemotherapy followed by autologous stem cell transplant has become standard care for high-risk cases, helping destroy remaining cancer cells while allowing the child's immune system to recover.
Radiation therapy may be used after surgery to eliminate remaining cancer cells in the tumor area.
Radiation therapy may be used after surgery to eliminate remaining cancer cells in the tumor area. Recent advances include targeted treatments like immunotherapy with anti-GD2 antibodies, which help the immune system recognize and attack neuroblastoma cells. Retinoid therapy with isotretinoin helps prevent cancer recurrence by encouraging any remaining neuroblasts to mature into normal nerve cells rather than continuing to multiply.
Treatment typically lasts 12-18 months for high-risk cases and may involve extended hospital stays.
Treatment typically lasts 12-18 months for high-risk cases and may involve extended hospital stays. Supportive care throughout treatment includes managing side effects, preventing infections, providing nutrition support, and helping families cope with the emotional challenges. Clinical trials continue exploring new approaches like targeted drugs that block specific genetic mutations, CAR-T cell therapy, and novel immunotherapy combinations that may further improve outcomes while reducing long-term complications.
Living With Neuroblastoma
Children and families living with neuroblastoma face both immediate treatment challenges and long-term adjustment needs. During active treatment, maintaining normal routines becomes difficult due to frequent hospital visits, side effects, and the child's changing energy levels. Many families find that creating flexible schedules, connecting with other families facing similar challenges, and working closely with social workers and child life specialists helps manage the emotional and practical demands of treatment.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 9, 2026v1.0.0
- Published by DiseaseDirectory